Topic Highlight
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2007; 13(30): 4064-4071
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4064
Table 1 Indications for endoscopic pancreatic sphincterotomy (EPS)
EPS as primary therapy
Sphincter of Oddi dysfunction (SOD)
-Pancreatic SOD
-Biliary SOD unresponsive to biliary sphincterotomy
Chronic pancreatitis with papillary stenosis/stricture
Pancreas divisum (EPS of the minor papilla)
EPS to facilitate a further intervention
Chronic pancreatitis treated with pancreatic stent and/or stone removal
Pancreatic pseudocyst treated with transpapillary drainage
Resection of an ampullary adenoma
Pancreatic fistula treated with stent placement
Pancreatic disease due to malignancy
-Primary pancreatic cancer causing strictures, stones, pseudocysts
-Metastatic disease to the pancreas causing strictures, stones,
Table 2 Complications of endoscopic pancreatic sphincterotomy (EPS)
Early Complications (< 3 mo, typically < 72 h)
Pancreatitis
Severe bleeding
Perforation
Pancreatic and/or biliary sepsis
Late Complications (> 3 mo)
Papillary stenosis
Proximal pancreatic duct strictures
Stent-related Complications (variable timing)
Ductal and parenchymal changes
Stone formation
Infection
Ductal perforation
Stent migration
Stent occlusion
Duodenal erosion